Literature DB >> 1504394

Development of a questionnaire for detecting potential adverse drug reactions.

D M Corso1, F Pucino, J M DeLeo, K A Calis, J F Gallelli.   

Abstract

OBJECTIVE: To develop a comprehensive list of symptoms categorized by body system as part of a questionnaire for detecting potential adverse drug reactions. DATA SOURCES: A preliminary list of symptoms in lay terminology was extracted from the "Side Effects" section of all drug monographs contained in the United States Pharmacopeia Dispensing Information (USP DI) computerized database (Volume II, Advice for the Patient) using natural language processing software. The list was sorted alphabetically and duplicate terms were eliminated. Symptoms were then categorized by body system or anatomic region. A preferred term for each symptom was selected when multiple synonyms and related words were listed. Finally, all of the symptom terms were incorporated into a thesaurus from which the questionnaire was derived.
RESULTS: The questionnaire will be used as part of a computer-assisted interview, developed to solicit information from patients regarding their medication regimens and to systematically query them regarding the presence of salient symptoms or complaints. The computer system will eventually interface with the USP DI database to identify drugs from a patient's regimen that may be associated with adverse symptoms. The symptom thesaurus will provide the link to the USP DI database. Preliminary experience with the questionnaire in a limited number of patients has been encouraging.
CONCLUSIONS: The questionnaire can assist clinicians in identifying drug-related symptoms including unreported adverse clinical effects of newly marketed or investigational therapeutic agents. When the questionnaire is computerized and linked to a comprehensive database, it can be more widely used to alert healthcare providers of potential adverse drug reactions that may otherwise go undetected.

Entities:  

Mesh:

Year:  1992        PMID: 1504394     DOI: 10.1177/106002809202600704

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  12 in total

Review 1.  Improving safety reporting from randomised trials.

Authors:  John P A Ioannidis; Joseph Lau
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Orthopedic complications of overweight in children and adolescents.

Authors:  Erica D Taylor; Kelly R Theim; Margaret C Mirch; Samareh Ghorbani; Marian Tanofsky-Kraff; Diane C Adler-Wailes; Sheila Brady; James C Reynolds; Karim A Calis; Jack A Yanovski
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

3.  Identifying Adverse Drug Events in Older Community-Dwelling Patients.

Authors:  Caitriona Cahir; Emma Wallace; Anthony Cummins; Conor Teljeur; Catherine Byrne; Kathleen Bennett; Tom Fahey
Journal:  Ann Fam Med       Date:  2019-03       Impact factor: 5.166

4.  Patient reporting of potential adverse drug reactions: a methodological study.

Authors:  N Jarernsiripornkul; J Krska; P A G Capps; R M E Richards; A Lee
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

5.  Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial.

Authors:  Andrew P Demidowich; Jordan A Levine; Ginikanwa I Onyekaba; Shahzaib M Khan; Kong Y Chen; Sheila M Brady; Miranda M Broadney; Jack A Yanovski
Journal:  Diabetes Obes Metab       Date:  2019-04-02       Impact factor: 6.577

6.  Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.

Authors:  J B Dumond; J L Adams; H M A Prince; R L Kendrick; R Wang; S H Jennings; S Malone; N White; C Sykes; A H Corbett; K B Patterson; A Forrest; A D M Kashuba
Journal:  HIV Med       Date:  2013-02-24       Impact factor: 3.180

7.  Defining and measuring meditation-related adverse effects in mindfulness-based programs.

Authors:  Willoughby B Britton; Jared R Lindahl; David J Cooper; Nicholas K Canby; Roman Palitsky
Journal:  Clin Psychol Sci       Date:  2021-11-01

8.  Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.

Authors:  Marieke Grenouillet-Delacre; Hélène Verdoux; Nicholas Moore; Françoise Haramburu; Ghada Miremont-Salamé; Gabriel Etienne; Philip Robinson; Didier Gruson; Gilles Hilbert; Claude Gabinski; Bernard Bégaud; Mathieu Molimard
Journal:  Intensive Care Med       Date:  2007-07-25       Impact factor: 17.440

9.  Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.

Authors:  Sieta T de Vries; Peter G M Mol; Dick de Zeeuw; Flora M Haaijer-Ruskamp; Petra Denig
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

10.  Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions.

Authors:  Jennifer R McDuffie; Karim A Calis; Gabriel I Uwaifo; Nancy G Sebring; Erica M Fallon; Teresa E Frazer; S Van Hubbard; Jack A Yanovski
Journal:  J Pediatr Endocrinol Metab       Date:  2004-03       Impact factor: 1.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.